Halozyme Therapeutics Inc
Closed
SectorHealthcare
69.43 -1.35
Overview
Share price change
24h
Min
69.21
Max
69.8
Income | 292M 150M |
|---|---|
Sales | -75M 377M |
P/E Sector Avg | 24.818 49.052 |
EPS | 1.221 |
Profit margin | 39.832 |
Employees | 423 |
EBITDA | -63M 218M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +23.45% upside |
Next Earnings | 4 Aug 2026 |
|---|
Market Cap | 740M 8.4B |
|---|---|
Previous open | 70.78 |
Previous close | 69.43 |
News Sentiment
By Acuity
50%
50%
146 / 342 Healthcare
Halozyme Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Halozyme Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 85.8 USD 23.45%
High 96 USD
Low 70 USD
Based on 5 Wall Street analysts offering 12 month price targets forHalozyme Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$